BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 10435061)

  • 1. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.
    Glendenning P; Kent GN; Adler BD; Matz L; Watson I; O'Driscoll GJ; Hurley DM
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):347-55. PubMed ID: 10435061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis in adult survivors of adolescent cardiac transplantation may be related to hyperparathyroidism, mild renal insufficiency, and increased bone turnover.
    Cohen A; Addonizio LJ; Lamour JM; Addesso V; Staron RB; Gao P; Shane E
    J Heart Lung Transplant; 2005 Jun; 24(6):696-702. PubMed ID: 15949729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation.
    Thiébaud D; Krieg MA; Gillard-Berguer D; Jacquet AF; Goy JJ; Burckhardt P
    Eur J Clin Invest; 1996 Jul; 26(7):549-55. PubMed ID: 8864416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex steroids, biochemical markers, bone mineral density and histomorphometry in male osteoporosis patients.
    Fassbender WJ; Balli M; Görtz B; Hinrichs B; Kaiser HE; Tracke HS
    In Vivo; 2000; 14(5):611-8. PubMed ID: 11125545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics.
    Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martinez de Osaba MJ; Ordi J; Rimola A; Rodés J; Muñoz-Gómez J
    Osteoporos Int; 2001; 12(6):484-92. PubMed ID: 11446565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of bone loss after cardiac transplantation.
    Guo CY; Johnson A; Locke TJ; Eastell R
    Bone; 1998 Mar; 22(3):267-71. PubMed ID: 9514219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP; Johnson CS; Vafai HT; Kaplan KC; Bailey J; Capwell B; Fraser F; Hansen L; Ramsay H; Shadoan M; Lees CJ; Thomsen JS; Mosekilde L
    Bone; 1999 Sep; 25(3):301-9. PubMed ID: 10495134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study.
    Cruz DN; Wysolmerski JJ; Brickel HM; Gundberg CG; Simpson CA; Mitnick MA; Kliger AS; Lorber MI; Basadonna GP; Friedman AL; Insogna KL; Bia MJ
    Transplantation; 2001 Jul; 72(1):83-8. PubMed ID: 11468539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis in men: a potential role for the sex hormone binding globulin.
    Legrand E; Hedde C; Gallois Y; Degasne I; Boux de Casson F; Mathieu E; Baslé MF; Chappard D; Audran M
    Bone; 2001 Jul; 29(1):90-5. PubMed ID: 11472897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of new markers of bone formation and resorption in kidney transplant recipients.
    Małyszko J; Wołczyński S; Małyszko JS; Konstantynowicz J; Kaczmarski M; Myśliwiec M
    Transplant Proc; 2003 Jun; 35(4):1351-4. PubMed ID: 12826157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone disease in long-term adult kidney transplant patients with normal renal function.
    Montalban C; de Francisco AL; Mariñoso ML; Zubimendi JA; García Unzueta M; Amado JA; Arias M
    Kidney Int Suppl; 2003 Jun; (85):S129-32. PubMed ID: 12753284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone loss and turnover after cardiac transplantation.
    Shane E; Rivas M; McMahon DJ; Staron RB; Silverberg SJ; Seibel MJ; Mancini D; Michler RE; Aaronson K; Addesso V; Lo SH
    J Clin Endocrinol Metab; 1997 May; 82(5):1497-506. PubMed ID: 9141540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.
    Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martinez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
    Calcif Tissue Int; 1997 Feb; 60(2):148-54. PubMed ID: 9056162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism.
    Roe SD; Porter CJ; Godber IM; Hosking DJ; Cassidy MJ
    Osteoporos Int; 2005 Feb; 16(2):142-8. PubMed ID: 15258722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
    Shane E; Rodino MA; McMahon DJ; Addesso V; Staron RB; Seibel MJ; Mancini D; Michler RE; Lo SH
    J Heart Lung Transplant; 1998 Nov; 17(11):1089-96. PubMed ID: 9855448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between bone turnover markers, bone mineral density and vitamin D in Moroccan postmenopausal women].
    Elmaataoui A; Elmachtani Idrissi S; Dami A; Bouhsain S; Chabraoui L; Ouzzif Z
    Pathol Biol (Paris); 2014 Feb; 62(1):49-54. PubMed ID: 24461391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis.
    Sahota O; Masud T; San P; Hosking DJ
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):217-21. PubMed ID: 10468993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.